CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025
CANBRIDGE-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
CANBRIDGE-B: POSTPONEMENT OF DATE OF BOARD MEETING
CANBRIDGE-B: DATE OF BOARD MEETING
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025
CANBRIDGE-B: DISCLOSEABLE TRANSACTION IN RELATION TO THE EARLY TERMINATION OF A LEASE AGREEMENT
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024
CANBRIDGE-B: CHANGE OF AUDITOR
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2024
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024
CANBRIDGE-B: VOLUNTARY ANNOUNCEMENT UPDATE ON THE GROUP'S BUSINESS OPERATIONS IN THE UNITED STATES
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
CANBRIDGE-B: VOLUNTARY ANNOUNCEMENT - ANNOUNCEMENT OF THE GRANT OF PRIORITY REVIEW STATUS OFCAN103 FOR THE TREATMENT OF GAUCHER DISEASE (GD)
CANBRIDGE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
CANBRIDGE-B: APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTORCHANGE IN COMPOSITION OF BOARD COMMITTEE
CANBRIDGE-B: RESIGNATION OF CHIEF FINANCIAL OFFICER
CANBRIDGE-B: INTERIM REPORT 2024
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
CANBRIDGE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS